To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Name: To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
License: Public Domain

Shanghai Bovax Biotechnology Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

hpv infection, hpv-related carcinoma, hpv-related intraepithelial neoplasia, genital wart

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 283081
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.